866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Adult Vaccines Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 105 Pages

In this report, the EMEA Adult Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K?Doses), revenue (Million USD), market share and growth rate of Adult Vaccines for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Adult Vaccines market competition by top manufacturers/players, with Adult Vaccines sales volume (K?Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline
Sanofi Pasteur
Merck
Novartis
Pfizer
BioCSL (Seqirus)
Protein Sciences
...

On the basis of product, this report displays the sales volume (K?Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into
Influenza
Cervical Cancer
Zoster Shingles
Pneumococcal
Meningococcal
MMRV
Hepatitis
DTP
Travel and Miscellaneous

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K?Doses), market share and growth rate of Adult Vaccines for each application, including
Medical Care
Healthy
Hospita

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Adult Vaccines Market Report 2017
1 Adult Vaccines Overview
1.1 Product Overview and Scope of Adult Vaccines
1.2 Classification of Adult Vaccines
1.2.1 EMEA Adult Vaccines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Adult Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Influenza
1.2.4 Cervical Cancer
1.2.5 Zoster Shingles
1.2.6 Pneumococcal
1.2.7 Meningococcal
1.2.8 MMRV
1.2.9 Hepatitis
1.2.10 DTP
1.2.11 Travel and Miscellaneous
1.3 EMEA Adult Vaccines Market by Application/End Users
1.3.1 EMEA Adult Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Medical Care
1.3.3 Healthy
1.3.4 Hospita
1.4 EMEA Adult Vaccines Market by Region
1.4.1 EMEA Adult Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Adult Vaccines (2012-2022)
1.5.1 EMEA Adult Vaccines Sales and Growth Rate (2012-2022)
1.5.2 EMEA Adult Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA Adult Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Adult Vaccines Market Competition by Players/Manufacturers
2.1.1 EMEA Adult Vaccines Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Adult Vaccines Revenue and Share by Players (2012-2017)
2.1.3 EMEA Adult Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Adult Vaccines (Volume and Value) by Type/Product Category
2.2.1 EMEA Adult Vaccines Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Adult Vaccines Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Adult Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Adult Vaccines (Volume) by Application
2.4 EMEA Adult Vaccines (Volume and Value) by Region
2.4.1 EMEA Adult Vaccines Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Adult Vaccines Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Adult Vaccines Sales Price by Region (2012-2017)

3 Europe Adult Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Adult Vaccines Sales and Value (2012-2017)
3.1.1 Europe Adult Vaccines Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Adult Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Adult Vaccines Sales and Market Share by Type
3.3 Europe Adult Vaccines Sales and Market Share by Application
3.4 Europe Adult Vaccines Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Adult Vaccines Sales Volume by Countries (2012-2017)
3.4.2 Europe Adult Vaccines Revenue by Countries (2012-2017)
3.4.3 Germany Adult Vaccines Sales and Growth Rate (2012-2017)
3.4.4 France Adult Vaccines Sales and Growth Rate (2012-2017)
3.4.5 UK Adult Vaccines Sales and Growth Rate (2012-2017)
3.4.6 Russia Adult Vaccines Sales and Growth Rate (2012-2017)
3.4.7 Italy Adult Vaccines Sales and Growth Rate (2012-2017)
3.4.8 Benelux Adult Vaccines Sales and Growth Rate (2012-2017)

4 Middle East Adult Vaccines (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Adult Vaccines Sales and Value (2012-2017)
4.1.1 Middle East Adult Vaccines Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Adult Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Adult Vaccines Sales and Market Share by Type
4.3 Middle East Adult Vaccines Sales and Market Share by Application
4.4 Middle East Adult Vaccines Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Adult Vaccines Sales Volume by Countries (2012-2017)
4.4.2 Middle East Adult Vaccines Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Adult Vaccines Sales and Growth Rate (2012-2017)
4.4.4 Israel Adult Vaccines Sales and Growth Rate (2012-2017)
4.4.5 UAE Adult Vaccines Sales and Growth Rate (2012-2017)
4.4.6 Iran Adult Vaccines Sales and Growth Rate (2012-2017)

5 Africa Adult Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Adult Vaccines Sales and Value (2012-2017)
5.1.1 Africa Adult Vaccines Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Adult Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Adult Vaccines Sales and Market Share by Type
5.3 Africa Adult Vaccines Sales and Market Share by Application
5.4 Africa Adult Vaccines Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Adult Vaccines Sales Volume by Countries (2012-2017)
5.4.2 Africa Adult Vaccines Revenue by Countries (2012-2017)
5.4.3 South Africa Adult Vaccines Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Adult Vaccines Sales and Growth Rate (2012-2017)
5.4.5 Egypt Adult Vaccines Sales and Growth Rate (2012-2017)
5.4.6 Algeria Adult Vaccines Sales and Growth Rate (2012-2017)

6 EMEA Adult Vaccines Manufacturers/Players Profiles and Sales Data
6.1 GlaxoSmithKline
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Adult Vaccines Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Adult Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sanofi Pasteur
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Adult Vaccines Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Pasteur Adult Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Adult Vaccines Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Adult Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novartis
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Adult Vaccines Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis Adult Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Adult Vaccines Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Adult Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 BioCSL (Seqirus)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Adult Vaccines Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 BioCSL (Seqirus) Adult Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Protein Sciences
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Adult Vaccines Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Protein Sciences Adult Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
...

7 Adult Vaccines Manufacturing Cost Analysis
7.1 Adult Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Adult Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Adult Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Adult Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Adult Vaccines Market Forecast (2017-2022)
11.1 EMEA Adult Vaccines Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Adult Vaccines Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Adult Vaccines Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Adult Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Adult Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Adult Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Adult Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Adult Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Adult Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Adult Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Adult Vaccines
Figure EMEA Adult Vaccines Sales Volume (K?Doses) by Type (2012-2022)
Figure EMEA Adult Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Influenza Product Picture
Figure Cervical Cancer Product Picture
Figure Zoster Shingles Product Picture
Figure Pneumococcal Product Picture
Figure Meningococcal Product Picture
Figure MMRV Product Picture
Figure Hepatitis Product Picture
Figure DTP Product Picture
Figure Travel and Miscellaneous Product Picture
Figure EMEA Adult Vaccines Sales Volume (K?Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Adult Vaccines by Application in 2016
Figure Medical Care Examples
Figure Healthy Examples
Figure Hospita Examples
Figure EMEA Adult Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Adult Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Adult Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Adult Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Adult Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Adult Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Adult Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Adult Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Adult Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Adult Vaccines Market Major Players Product Sales Volume (K?Doses) (2012-2017)
Table EMEA Adult Vaccines Sales Volume (K?Doses) of Major Players (2012-2017)
Table EMEA Adult Vaccines Sales Share by Players (2012-2017)
Figure 2016 Adult Vaccines Sales Share by Players
Figure 2017 Adult Vaccines Sales Share by Players
Figure EMEA Adult Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Adult Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Adult Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Adult Vaccines Revenue Share by Players
Table 2017 EMEA Adult Vaccines Revenue Share by Players
Table EMEA Adult Vaccines Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Adult Vaccines Sales (K?Doses) and Market Share by Type (2012-2017)
Table EMEA Adult Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Adult Vaccines by Type (2012-2017)
Figure EMEA Adult Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Adult Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Adult Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Adult Vaccines by Type in 2016
Table EMEA Adult Vaccines Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Adult Vaccines Sales (K?Doses) and Market Share by Application (2012-2017)
Table EMEA Adult Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Adult Vaccines by Application (2012-2017)
Figure EMEA Adult Vaccines Sales Market Share by Application in 2016
Table EMEA Adult Vaccines Sales (K?Doses) and Market Share by Region (2012-2017)
Table EMEA Adult Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Adult Vaccines by Region (2012-2017)
Figure EMEA Adult Vaccines Sales Market Share in 2016
Table EMEA Adult Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Adult Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Adult Vaccines by Region (2012-2017)
Figure EMEA Adult Vaccines Revenue Market Share Regions in 2016
Table EMEA Adult Vaccines Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Europe Adult Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Adult Vaccines Sales (K?Doses) by Type (2012-2017)
Table Europe Adult Vaccines Market Share by Type (2012-2017)
Figure Europe Adult Vaccines Market Share by Type in 2016
Table Europe Adult Vaccines Sales (K?Doses) by Application (2012-2017)
Table Europe Adult Vaccines Market Share by Application (2012-2017)
Figure Europe Adult Vaccines Market Share by Application in 2016
Table Europe Adult Vaccines Sales (K?Doses) by Countries (2012-2017)
Table Europe Adult Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Adult Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Adult Vaccines Sales Market Share by Countries in 2016
Table Europe Adult Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Adult Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Adult Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Adult Vaccines Revenue Market Share by Countries in 2016
Figure Germany Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure France Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure UK Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Russia Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Italy Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Benelux Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Middle East Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Middle East Adult Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Adult Vaccines Sales (K?Doses) by Type (2012-2017)
Table Middle East Adult Vaccines Market Share by Type (2012-2017)
Figure Middle East Adult Vaccines Market Share by Type (2012-2017)
Table Middle East Adult Vaccines Sales (K?Doses) by Applications (2012-2017)
Table Middle East Adult Vaccines Market Share by Applications (2012-2017)
Figure Middle East Adult Vaccines Sales Market Share by Application in 2016
Table Middle East Adult Vaccines Sales Volume (K?Doses) by Countries (2012-2017)
Table Middle East Adult Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Adult Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Adult Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Adult Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Adult Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Adult Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Israel Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure UAE Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Iran Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Africa Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Africa Adult Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Adult Vaccines Sales (K?Doses) by Type (2012-2017)
Table Africa Adult Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Adult Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Adult Vaccines Sales Market Share by Type in 2016
Table Africa Adult Vaccines Sales (K?Doses) by Application (2012-2017)
Table Africa Adult Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Adult Vaccines Sales Market Share by Application (2012-2017)
Table Africa Adult Vaccines Sales Volume (K?Doses) by Countries (2012-2017)
Table Africa Adult Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Adult Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Adult Vaccines Sales Market Share by Countries in 2016
Table Africa Adult Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Adult Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Adult Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Adult Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Nigeria Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Egypt Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Algeria Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Table GlaxoSmithKline Adult Vaccines Basic Information List
Table GlaxoSmithKline Adult Vaccines Sales (K?Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Adult Vaccines Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Adult Vaccines Revenue Market Share in EMEA (2012-2017)
Table Sanofi Pasteur Adult Vaccines Basic Information List
Table Sanofi Pasteur Adult Vaccines Sales (K?Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Sanofi Pasteur Adult Vaccines Sales Market Share in EMEA (2012-2017)
Figure Sanofi Pasteur Adult Vaccines Revenue Market Share in EMEA (2012-2017)
Table Merck Adult Vaccines Basic Information List
Table Merck Adult Vaccines Sales (K?Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merck Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Merck Adult Vaccines Sales Market Share in EMEA (2012-2017)
Figure Merck Adult Vaccines Revenue Market Share in EMEA (2012-2017)
Table Novartis Adult Vaccines Basic Information List
Table Novartis Adult Vaccines Sales (K?Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Novartis Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Novartis Adult Vaccines Sales Market Share in EMEA (2012-2017)
Figure Novartis Adult Vaccines Revenue Market Share in EMEA (2012-2017)
Table Pfizer Adult Vaccines Basic Information List
Table Pfizer Adult Vaccines Sales (K?Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Pfizer Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Pfizer Adult Vaccines Sales Market Share in EMEA (2012-2017)
Figure Pfizer Adult Vaccines Revenue Market Share in EMEA (2012-2017)
Table BioCSL (Seqirus) Adult Vaccines Basic Information List
Table BioCSL (Seqirus) Adult Vaccines Sales (K?Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure BioCSL (Seqirus) Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure BioCSL (Seqirus) Adult Vaccines Sales Market Share in EMEA (2012-2017)
Figure BioCSL (Seqirus) Adult Vaccines Revenue Market Share in EMEA (2012-2017)
Table Protein Sciences Adult Vaccines Basic Information List
Table Protein Sciences Adult Vaccines Sales (K?Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Protein Sciences Adult Vaccines Sales (K?Doses) and Growth Rate (2012-2017)
Figure Protein Sciences Adult Vaccines Sales Market Share in EMEA (2012-2017)
Figure Protein Sciences Adult Vaccines Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adult Vaccines
Figure Manufacturing Process Analysis of Adult Vaccines
Figure Adult Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Adult Vaccines Major Manufacturers in 2016
Table Major Buyers of Adult Vaccines
Table Distributors/Traders List
Figure EMEA Adult Vaccines Sales (K?Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Adult Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Adult Vaccines Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Adult Vaccines Sales (K?Doses) Forecast by Region (2017-2022)
Figure EMEA Adult Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Adult Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Adult Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Adult Vaccines Sales (K?Doses) Forecast by Countries (2017-2022)
Figure Europe Adult Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Adult Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Adult Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Adult Vaccines Sales (K?Doses) Forecast by Countries (2017-2022)
Figure Middle East Adult Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Adult Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Adult Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Adult Vaccines Sales (K?Doses) Forecast by Countries (2017-2022)
Figure Africa Adult Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Adult Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Adult Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Adult Vaccines Sales (K?Doses) Forecast by Type (2017-2022)
Figure EMEA Adult Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Adult Vaccines Sales (K?Doses) Forecast by Application (2017-2022)
Figure EMEA Adult Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *